MetaVia Inc. (MTVA): debt financing — NeuroBo Pharma HQ moves to 177 Huntington Ave, Boston under new 3-year lease

MetaVia Inc.

New 3-year lease for ~2,441 sq ft at 177 Huntington Ave, Boston, effective Sep 1, 2023.
Annual rent: $85,435 (yr1), $87,998 (yr2), $90,634 (yr3); option for 2-year extension at higher rates.
Current lease at 200 Berkeley St terminated effective Sep 30, 2023.
Lease includes standard indemnification, insurance requirements, and default provisions.

item 1.01 item 1.02 item 2.03

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

MetaVia Inc. incurred lease obligation with Alewife Properties LLC maturing three (3) years.

Instrument: lease obligation
Counterparty: Alewife Properties LLC
Maturity: three (3) years
Event: incurrence

Exact text from the filing

On August 23, 2023, NeuroBo Pharmaceuticals, Inc. (the “Company” ) entered into a Standard Form Lease Agreement (the “Lease Agreement” ) with Alewife Properties LLC (the “Landlord” ), to lease certain office space of approximately 2,441 square feet located at 177 Huntington Avenue, Suite 1732, Boston, Massachusetts, 02115, also known as 545 Concord Avenue (the “Premises” ).

View on SEC.gov

54 debt financings filed in the last 30 days. Browse all debt financings →

MetaVia Inc. filing history →

Source: SEC EDGAR

accession 0001558370-23-015255

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.